FDA Drug Recalls

Recalls / Class II

Class IID-927-2013

Product

Diazepam Injection, USP, 5 mg/mL, 10 mL, Multiple-dose Sterile Non-pyrogenic, Fliptop Vial, C-IV, Rx Only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-3213-12

Brand name
Diazepam
Generic name
Diazepam
Active ingredient
Diazepam
Route
Intramuscular, Intravenous
NDC
0409-3213
FDA application
ANDA071583
Affected lot / code info
Lot: 23-505-EV, Exp. 11/14

Why it was recalled

Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.

Recalling firm

Firm
Hospira Inc.
Manufacturer
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
275 N Field Dr, Lake Forest, Illinois 60045-2579

Distribution

Quantity
72,300 vials
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2013-08-16
FDA classified
2013-08-28
Posted by FDA
2013-09-04
Terminated
2014-10-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-927-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.